CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Immunizations - travel vaccinations - Management
Meningococcal A, C, W135 and Y vaccine
Age from 1 month to 11 months
Menveo® (conjugate vaccine): age under 1 year
Menveo vaccine powder and solvent for solution for injection 0.5ml vials
Give 0.5ml by intramuscular injection. For primary immunization, give two doses on days 0 and 28.
Supply 1 0.5ml vial+diluent.
Age from 1 year to 10 years 11 months
Menveo® (conjugate vaccine): age 1 to 11 years
Menveo vaccine powder and solvent for solution for injection 0.5ml vials
Give 0.5ml by intramuscular injection.
Supply 1 0.5ml vial+diluent.
Age from 5 years onwards
Less preferred: ACWY Vax® (polysaccharide vaccine)
ACWY Vax powder and solvent for solution for injection 0.5ml vials
Give 0.5ml by deep subcutaneous injection.
Supply 1 0.5ml vial+diluent.
Age from 11 years onwards
Menveo® (conjugate vaccine): age 11 years and older
Menveo vaccine powder and solvent for solution for injection 0.5ml vials
Give 0.5ml by intramuscular injection.
Supply 1 0.5ml vial+diluent.
© NHS Institute for Innovation and Improvement